MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-08-2026
OraSure Technologies Operating Expenses 2011-2026 | OSUR
Annual Operating Expenses OraSure Technologies
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120 M | 108 M | 139 M | 171 M | 128 M | 107 M | 86.8 M | 85.2 M | 71.2 M | 67.8 M | 72.2 M | 76.9 M | 79.1 M | 71.8 M | 61.1 M | 50.7 M | 55.9 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 171 M | 50.7 M | 91.2 M |
Quarterly Operating Expenses OraSure Technologies
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35.1 M | 27.9 M | 31.2 M | 30 M | - | 23.1 M | 27.4 M | 31.2 M | - | 33.4 M | 32.8 M | 41.5 M | - | 45.3 M | 49.3 M | 40.5 M | - | 34.5 M | 28.9 M | 27.9 M | - | 25.9 M | 26.7 M | 24.2 M | - | 8.59 M | 19.7 M | 21.9 M | - | 17.7 M | 20.3 M | 25 M | - | 17.3 M | 18.6 M | 4.44 M | - | 16.5 M | 16.7 M | 17.6 M | - | 19.1 M | 18 M | 17.3 M | - | 17.8 M | 13.5 M | 19.5 M | - | 17 M | 20.1 M | 22.6 M | - | 16.8 M | 18.2 M | 17.4 M | - | 17.8 M | 14.6 M | 13.8 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 49.3 M | 4.44 M | 23.6 M |
Operating Expenses of other stocks in the Medical instruments industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
1.23 B | $ 59.61 | -1.28 % | $ 11.9 B |  USA |
 |
Atrion Corporation
ATRI
|
39.8 K | - | - | $ 810 M | USA |
 |
Luminex Corporation
LMNX
|
205 M | - | - | $ 1.75 B | USA |
 |
iRhythm Technologies
IRTC
|
585 M | $ 114.0 | -0.14 % | $ 3.65 B | USA |
 |
ICU Medical
ICUI
|
779 M | $ 118.72 | -3.47 % | $ 2.93 B | USA |
 |
Repro Med Systems
KRMD
|
28.6 M | $ 3.9 | -2.01 % | $ 180 M | USA |
 |
Akers Biosciences, Inc.
AKER
|
7.99 M | - | -9.52 % | $ 20.6 M | USA |
 |
Intuitive Surgical
ISRG
|
3.7 B | $ 421.12 | -1.62 % | $ 150 B | USA |
 |
LeMaitre Vascular
LMAT
|
111 M | $ 97.31 | -2.2 % | $ 2.2 B | USA |
 |
Alcon
ALC
|
3.37 B | $ 63.64 | -0.56 % | $ 40.4 B |  Schweiz |
 |
Masimo Corporation
MASI
|
1.27 B | $ 178.47 | 0.07 % | $ 9.51 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
72.9 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
388 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
8.44 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
1.07 B | - | -0.05 % | $ 10.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
20.2 M | - | - | $ 28.6 M | USA |
 |
Envista Holdings Corporation
NVST
|
2.27 B | $ 23.22 | -2.68 % | $ 3.9 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
1.05 B | - | -0.02 % | $ 16.3 B | USA |
 |
electroCore
ECOR
|
40.9 M | $ 6.27 | -2.49 % | $ 53.2 K | USA |
 |
Haemonetics Corporation
HAE
|
527 M | $ 56.29 | -1.4 % | $ 2.83 B | USA |
 |
Isoray
ISR
|
114 M | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
368 M | $ 144.01 | 1.31 % | $ 6.97 B | USA |
 |
STAAR Surgical Company
STAA
|
100 M | $ 32.07 | 0.19 % | $ 1.59 B | USA |
 |
STERIS plc
STE
|
1.54 B | $ 212.11 | -1.79 % | $ 20.9 B | USA |
 |
Teleflex Incorporated
TFX
|
1.05 B | $ 129.71 | -0.44 % | $ 5.79 B | USA |
 |
InfuSystem Holdings
INFU
|
68.4 M | $ 8.77 | 1.86 % | $ 181 M | USA |
 |
Microbot Medical
MBOT
|
9.09 K | $ 1.85 | - | $ 84.7 M |  Israel |
 |
Milestone Scientific
MLSS
|
12.1 M | $ 0.33 | -2.62 % | $ 27.1 M | USA |
 |
Merit Medical Systems
MMSI
|
554 M | $ 61.36 | -1.92 % | $ 3.63 B | USA |
 |
Utah Medical Products
UTMD
|
11.8 M | $ 63.34 | -0.57 % | $ 205 M | USA |
 |
West Pharmaceutical Services
WST
|
301 M | $ 302.89 | 0.9 % | $ 21.9 B | USA |
 |
Pulse Biosciences
PLSE
|
48 M | $ 24.55 | -9.41 % | $ 1.65 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.72 B | $ 10.08 | -3.17 % | $ 2.01 B | USA |
 |
Retractable Technologies
RVP
|
21.2 M | $ 0.64 | -7.25 % | $ 19.2 M | USA |
 |
Pro-Dex
PDEX
|
8.82 M | $ 59.27 | 1.06 % | $ 195 M | USA |
 |
Predictive Oncology
POAI
|
13.1 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
17.8 M | $ 20.76 | -1.42 % | $ 991 M | USA |
 |
Stereotaxis
STXS
|
39.2 M | $ 1.85 | -4.64 % | $ 168 M | USA |
 |
Baxter International
BAX
|
3.88 B | $ 17.3 | -2.7 % | $ 8.87 B | USA |
 |
ResMed
RMD
|
1.02 B | $ 201.88 | -0.33 % | $ 29.5 B | USA |
 |
AtriCure
ATRC
|
410 M | $ 28.12 | -0.11 % | $ 1.34 B | USA |
 |
Harvard Bioscience
HBIO
|
98.5 M | $ 5.25 | -4.89 % | $ 233 M | USA |
 |
NeuroMetrix
NURO
|
10.5 M | - | 5.05 % | $ 9.02 M | USA |
 |
AngioDynamics
ANGO
|
198 M | $ 10.77 | -2.36 % | $ 440 M | USA |
 |
Becton, Dickinson and Company
BDX
|
6.05 B | $ 143.47 | -0.73 % | $ 41.3 B | USA |
 |
Nephros
NEPH
|
10.5 M | $ 3.13 | -6.29 % | $ 33.2 M | USA |
 |
Repligen Corporation
RGEN
|
115 M | $ 102.87 | -0.49 % | $ 5.78 M | USA |